These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36063841)

  • 1. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
    Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
    Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease.
    Xanthopoulou V; Räisänen IT; Sorsa T; Tortopidis D; Sakellari D
    Clin Exp Dent Res; 2024 Jun; 10(3):e883. PubMed ID: 38853451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of procalcitonin in saliva and peri-implant crevicular fluid in patients with peri-implant diseases and health.
    Algohar A; Alqerban A
    Arch Oral Biol; 2020 Dec; 120():104931. PubMed ID: 33113457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.
    Keskin M; Rintamarttunen J; Gülçiçek E; Räisänen IT; Gupta S; Tervahartiala T; Pätilä T; Sorsa T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy.
    Ziebolz D; Schmalz G; Gollasch D; Eickholz P; Rinke S
    Diagn Microbiol Infect Dis; 2017 May; 88(1):47-52. PubMed ID: 28274501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis.
    Lähteenmäki H; Pätilä T; Pärnänen CP; Räisänen I; Tervahartiala T; Gupta S; Sorsa T
    Expert Opin Ther Targets; 2023; 27(7):627-637. PubMed ID: 37522314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Peri-Implant Marginal Bone Loss Progression and a-MMP-8 Be Considered Indicators of the Subsequent Onset of Peri-Implantitis? A 5-Year Study.
    Guarnieri R; Reda R; Zanza A; Miccoli G; Nardo DD; Testarelli L
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and radiographic peri-implant parameters and proinflammatory cytokine levels among cigarette smokers, smokeless tobacco users, and nontobacco users.
    Akram Z; Vohra F; Bukhari IA; Sheikh SA; Javed F
    Clin Implant Dent Relat Res; 2018 Feb; 20(1):76-81. PubMed ID: 29243410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fermented lingonberry juice's effects on active MMP-8 (aMMP-8), bleeding on probing (BOP), and visible plaque index (VPI) in dental implants-A clinical pilot mouthwash study.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Sorsa T
    Clin Exp Dent Res; 2022 Dec; 8(6):1322-1330. PubMed ID: 35894289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.
    Al-Majid A; Alassiri S; Rathnayake N; Tervahartiala T; Gieselmann DR; Sorsa T
    Int J Dent; 2018; 2018():7891323. PubMed ID: 30305812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between peri-implant sulcular fluid rate and expression of collagenase2 (MMP8).
    Janska E; Mohr B; Wahl G
    Clin Oral Investig; 2016 Mar; 20(2):261-6. PubMed ID: 26077894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
    Galofré M; Palao D; Vicario M; Nart J; Violant D
    J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy.
    Schmalz G; Kummer MK; Kottmann T; Rinke S; Haak R; Krause F; Schmidt J; Ziebolz D
    J Periodontal Implant Sci; 2018 Aug; 48(4):251-260. PubMed ID: 30202608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.